![Final Rule Confirms, Posting of Study Results on ClinicalTrials.gov Will be Required for Unapproved Products - IMPACT Pharmaceutical Services, Inc. Final Rule Confirms, Posting of Study Results on ClinicalTrials.gov Will be Required for Unapproved Products - IMPACT Pharmaceutical Services, Inc.](http://www.impactpharma.com/wp-content/uploads/2015/09/c.jpg)
Final Rule Confirms, Posting of Study Results on ClinicalTrials.gov Will be Required for Unapproved Products - IMPACT Pharmaceutical Services, Inc.
![Clinical Trials - Grey Literature in the Health Sciences - Research Guides at University of Alabama - Birmingham Clinical Trials - Grey Literature in the Health Sciences - Research Guides at University of Alabama - Birmingham](https://s3.amazonaws.com/libapps/accounts/200/images/Grey_Lit_2.gif)
Clinical Trials - Grey Literature in the Health Sciences - Research Guides at University of Alabama - Birmingham
![A Guide to Understanding Clinical Trials: Part 2 - Five Factors to Consider When Evaluating Results - Bench Press A Guide to Understanding Clinical Trials: Part 2 - Five Factors to Consider When Evaluating Results - Bench Press](https://i0.wp.com/mgriblog.org/wp-content/uploads/2020/06/MGRI-Clinical-trials-explainer-Insta-01-1.png?resize=1024%2C1024&ssl=1)
A Guide to Understanding Clinical Trials: Part 2 - Five Factors to Consider When Evaluating Results - Bench Press
How Frequently Do the Results from Completed US Clinical Trials Enter the Public Domain? - A Statistical Analysis of the ClinicalTrials.gov Database | PLOS ONE
![Amplifying the Voice of the Patient in Clinical Research: Development of Toolkits for Use in Designing and Conducting Patient-Centered Clinical Studies | SpringerLink Amplifying the Voice of the Patient in Clinical Research: Development of Toolkits for Use in Designing and Conducting Patient-Centered Clinical Studies | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs43441-020-00176-6/MediaObjects/43441_2020_176_Fig2_HTML.png)
Amplifying the Voice of the Patient in Clinical Research: Development of Toolkits for Use in Designing and Conducting Patient-Centered Clinical Studies | SpringerLink
![Characteristics of registered clinical trials assessing treatments for COVID-19: a cross-sectional analysis | BMJ Open Characteristics of registered clinical trials assessing treatments for COVID-19: a cross-sectional analysis | BMJ Open](https://bmjopen.bmj.com/content/bmjopen/10/6/e039978/F2.large.jpg?width=800&height=600&carousel=1)
Characteristics of registered clinical trials assessing treatments for COVID-19: a cross-sectional analysis | BMJ Open
![Statistical controversies in clinical research: limitations of open-label studies assessing antiangiogenic therapies with regard to evaluation of vascular adverse drug events—a meta-analysis - Annals of Oncology Statistical controversies in clinical research: limitations of open-label studies assessing antiangiogenic therapies with regard to evaluation of vascular adverse drug events—a meta-analysis - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/4ba8a139-a98a-4306-9ae7-443a9ad74d47/gr1_lrg.jpg)